MyFinsight
Home
About
Contact
Back
Income Statement
Denali Therapeutics Inc. (DNLI)
source: myfinsight.com
Download
Download image
Comprehensive loss
-$125,217,000
(-24.73%↓ Y/Y)
Net loss
-$124,119,000
(-25.34%↓ Y/Y)
Net unrealized loss
on marketable...
-$1,098,000
(19.44%↑ Y/Y)
Interest and other
income, net
$10,844,000
(-38.27%↓ Y/Y)
Loss from operations
-$134,963,000
(-15.76%↓ Y/Y)
Total operating
expenses
$134,963,000
(15.76%↑ Y/Y)
General and
administrative
$32,267,000
(28.07%↑ Y/Y)
Research and development
$102,696,000
(12.36%↑ Y/Y)
Back